As one of the main threats to human life (the fourth most dangerous and prevalent cancer),
colorectal cancer affects many people yearly, decreases patients' quality of life, and causes …

Colorectal cancer is prevalent worldwide, with various factors influencing the survival rate of
late-stage metastatic cases. Current standard treatments include surgical removal, adjuvant …

There are increasing incidences and mortality rates for colorectal cancer in the world. It is
common for chemotherapy and radiation given to patients with colorectal cancer to cause …

Cancer immunotherapy has become an indispensable mode of treatment for a multitude of
solid tumor cancers. Colorectal cancer (CRC) has been one of the many cancer types to …

Introduction: In the last few years, significant advances in molecular biology have provided
new therapeutic options for colorectal cancer (CRC). The development of new drugs that …

Introduction: Colorectal cancer (CRC) is the fourth most common cancer and the second
leading cause of cancer-related death worldwide. Surgery, chemotherapy, radiation therapy …

Colorectal cancer is the third most common cancer in the world with increasing incidence
and mortality rates globally. Standard treatments for colorectal cancer have always been …

After decades of progress based on chemotherapy and targeted agents, patients with
metastatic colorectal cancer still have low long-term survival, with more than 500,000 deaths …

Background Immunotherapy focuses on selectively enhancing the host's immune response
against malignant disease. It has been investigated as an important treatment modality …

Human colorectal cancer (CRC) is the third most commonly diagnosed malignancies and
the prognosis for patients with recurrent or metastatic disease is extremely poor. Although …